[1]
A. Payne and S. Oh, “MuSK-CAART: A novel precision cellular therapy for muscle-specific tyrosine kinase myasthenia gravis : Precision cellular therapy for MuSK myasthenia gravis”, rrnmf, vol. 4, no. 3, Aug. 2023, doi: 10.17161/rrnmf.v4i3.19417.